Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, GoodRx Holdings, Inc. reported revenue of $797M, up 0.6% year over year. Operating margin was 11.0% and net margin 3.8%, on a free-cash-flow margin of 20.6% with capital expenditure at 0.4% of revenue. Every figure is computed directly from GDRX's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $797M | 11.0% | 3.8% |
| FY2024 | $792M | 8.3% | 2.1% |
| FY2023 | $750M | -3.6% | -1.2% |
| FY2022 | $767M | 0.2% | -4.3% |
| FY2021 | $745M | 1.8% | -3.4% |
How does GDRX compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: ABM · ACIW · ACN · ACVA · ADBE · ADMQ
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.